SPC for COVID-19 mRNA Vaccine BNT162b2 (Pfizer) available via EMC

This does not have a marketing authorisation, but authorisation by DHSC and MHRA grants permission for it be used for active immunization to prevent COVID-19 disease caused by SARS-CoV-2 virus in individuals aged 16 years of age and over.

electronic Medicines compendium